Get started
CONMED CORP. DL-,01CONMED CORP. DL-,01CONMED CORP. DL-,01

CONMED CORP. DL-,01

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

EC8 chart


Full chart

EC8 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.58 B‬ EUR
Dividend yield (indicated)
1.38%
Price to earnings Ratio (TTM)
14.4
Basic EPS (TTM)
3.6 EUR
Net income (FY)
‪127.92 M‬ EUR
Revenue (FY)
‪1.26 B‬ EUR
Shares float
‪30.07 M‬
Beta (1Y)
0.39

Employees


Employees (FY)
‪3.9 K‬
Change (1Y)
−100 −2.50%
Revenue / Employee (1Y)
‪322.67 K‬ EUR
Net income / Employee (1Y)
‪32.80 K‬ EUR

About CONMED Corporation


Sector
Health Technology
Industry
Medical Specialties
CEO
Patrick Joseph Beyer
Website
conmed.com
Headquarters
Largo
Founded
1970
FIGI
BBG000GQH1Z5
CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. Its products include AirSeal and insufflation, allograft cartilage and tissue, arthroplasty, biliary and endoscopic ultrasound, biomedical sensors and electrodes, biopsy and polypectomy, dilators and accessories, electrosurgical units, fixation devices, hemostasis, implants and suture anchors, infection prevention, patient positioning, and related products. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

EC8 news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

EC8 highest yielding bonds


CNMD5600366
CONMED Corporation 2.25% 15-JUN-2027
Yield to maturity
4.96%
Maturity date
Jun 15, 2027

See all EC8 bonds 


Check out other big names from the same industry as EC8.

Frequently Asked Questions


The current price of EC8 is 51.0 EUR — it has increased by 4.51% in the past 24 hours. Watch CONMED CORP. DL-,01 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange CONMED CORP. DL-,01 stocks are traded under the ticker EC8.
EC8 stock has fallen by −1.92% compared to the previous week, the month change is a 16.44% rise, over the last year CONMED CORP. DL-,01 has showed a −25.00% decrease.
We've gathered analysts' opinions on CONMED CORP. DL-,01 future price: according to them, EC8 price has a max estimate of 70.62 EUR and a min estimate of 50.32 EUR. Watch EC8 chart and read a more detailed CONMED CORP. DL-,01 stock forecast: see what analysts think of CONMED CORP. DL-,01 and suggest that you do with its stocks.
EC8 reached its all-time high on Apr 21, 2022 with the price of 141.0 EUR, and its all-time low was 9.0 EUR and was reached on Mar 9, 2009. View more price dynamics on EC8 chart.
See other stocks reaching their highest and lowest prices.
EC8 stock is 0.00% volatile and has beta coefficient of 0.39. Track CONMED CORP. DL-,01 stock price on the chart and check out the list of the most volatile stocks — is CONMED CORP. DL-,01 there?
Today CONMED CORP. DL-,01 has the market capitalization of ‪1.56 B‬, it has decreased by −8.28% over the last week.
Yes, you can track CONMED CORP. DL-,01 financials in yearly and quarterly reports right on TradingView.
CONMED CORP. DL-,01 is going to release the next earnings report on Jul 23, 2025. Keep track of upcoming events with our Earnings Calendar.
EC8 earnings for the last quarter are 0.88 EUR per share, whereas the estimation was 0.75 EUR resulting in a 17.08% surprise. The estimated earnings for the next quarter are 0.99 EUR per share. See more details about CONMED CORP. DL-,01 earnings.
CONMED CORP. DL-,01 revenue for the last quarter amounts to ‪296.95 M‬ EUR, despite the estimated figure of ‪289.69 M‬ EUR. In the next quarter, revenue is expected to reach ‪299.69 M‬ EUR.
EC8 net income for the last quarter is ‪5.58 M‬ EUR, while the quarter before that showed ‪32.61 M‬ EUR of net income which accounts for −82.89% change. Track more CONMED CORP. DL-,01 financial stats to get the full picture.
Yes, EC8 dividends are paid quarterly. The last dividend per share was 0.18 EUR. As of today, Dividend Yield (TTM)% is 1.40%. Tracking CONMED CORP. DL-,01 dividends might help you take more informed decisions.
CONMED CORP. DL-,01 dividend yield was 1.17% in 2024, and payout ratio reached 18.82%. The year before the numbers were 0.73% and 39.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 29, 2025, the company has ‪3.9 K‬ employees. See our rating of the largest employees — is CONMED CORP. DL-,01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CONMED CORP. DL-,01 EBITDA is ‪182.99 M‬ EUR, and current EBITDA margin is 16.54%. See more stats in CONMED CORP. DL-,01 financial statements.
Like other stocks, EC8 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CONMED CORP. DL-,01 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CONMED CORP. DL-,01 technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CONMED CORP. DL-,01 stock shows the sell signal. See more of CONMED CORP. DL-,01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.